GX Molecular Inc.

Biotechnology company · Cambridge, England, United Kingdom

GX Molecular Inc. is a biotechnology company headquartered in Cambridge, England, United Kingdom. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $2.2 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

GX Molecular at a glance

Typebiotechnology company

HeadquartersCambridge, England, United Kingdom

Earliest incorporation on record2019

SEC CIK1866545

What does GX Molecular do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.2 million sold (2021).

Frequently asked questions about GX Molecular

Where is GX Molecular headquartered?

GX Molecular Inc. is headquartered in Cambridge, England, United Kingdom.

What does GX Molecular do?

GX Molecular Inc. is a biotechnology company.

When was GX Molecular founded?

The earliest incorporation on record for GX Molecular Inc. is in 2019, according to public company registers.

Similar companies

Abcam plcCambridge, England, United Kingdom
Inivata LtdCambridge, England, United Kingdom
Biosceptre International LtdCambridge, England, United Kingdom
Nxera Pharma UK LimitedCambridge, England, United Kingdom
Vernalis (R&D) LimitedCambridge, England, United Kingdom
Apollo Therapeutics LimitedCambridge, England, United Kingdom
Artios Pharma LimitedCambridge, England, United Kingdom
Cerevance, LtdCambridge, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences